Susan Quaggin
Director/Miembro de la Junta en ABBVIE INC. .
Fortuna: 221 157 $ al 30/04/2024
Cargos activos de Susan Quaggin
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ABBVIE INC. | Director/Miembro de la Junta | 11/10/2023 | - |
| Independent Dir/Board Member | 11/10/2023 | - | |
Mannin Research, Inc.
 Mannin Research, Inc. BiotechnologyHealth Technology Mannin Research, Inc. develops novel therapeutics for vascular diseases. It also operates a research platform that develops a class of drugs to treat diseases such as glaucoma and cystic kidney disease. The company is headquartered in Toronto, Canada. | Director/Miembro de la Junta | - | - |
| Director Técnico/Científico/I+D | - | - | |
American Society of Nephrology
 American Society of Nephrology Medical/Nursing ServicesHealth Services American Society of Nephrology operates as a professional society devoted to the study of kidney disease. The company is headquartered in Washington, DC. | Director/Miembro de la Junta | - | - |
| Feinberg School of Medicine | Corporate Officer/Principal | - | - |
Historial de carrera de Susan Quaggin
Estadísticas
Internacional
| Estados Unidos | 4 |
| Canadá | 2 |
Operativa
| Director/Board Member | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Independent Dir/Board Member | 1 |
Sectorial
| Health Technology | 3 |
| Health Services | 2 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ABBVIE INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
American Society of Nephrology
American Society of Nephrology Medical/Nursing ServicesHealth Services American Society of Nephrology operates as a professional society devoted to the study of kidney disease. The company is headquartered in Washington, DC. | Health Services |
Mannin Research, Inc.
Mannin Research, Inc. BiotechnologyHealth Technology Mannin Research, Inc. develops novel therapeutics for vascular diseases. It also operates a research platform that develops a class of drugs to treat diseases such as glaucoma and cystic kidney disease. The company is headquartered in Toronto, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- Susan Quaggin
- Experiencia
